U T MD Anderson Cancer Center Investigational Pharmacy Services — Houston, Texas

U T MD Anderson Cancer Center Investigational Pharmacy Services is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

U T MD Anderson Cancer Center Investigational Pharmacy Services has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: Ningbo Newbay Technology Development Co., Ltd.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for U T MD Anderson Cancer Center Investigational Pharmacy Services?

U T MD Anderson Cancer Center Investigational Pharmacy Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has U T MD Anderson Cancer Center Investigational Pharmacy Services conducted?

U T MD Anderson Cancer Center Investigational Pharmacy Services has 1 clinical trials on record. Their work covers Advanced Solid Tumor.

Is U T MD Anderson Cancer Center Investigational Pharmacy Services accredited by Crixeo Health?

U T MD Anderson Cancer Center Investigational Pharmacy Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about U T MD Anderson Cancer Center Investigational Pharmacy Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.